Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g Vct5 Regulatory News (MIG5)

Share Price Information for Maven I&g Vct5 (MIG5)

Share Price is delayed by 15 minutes
Get Live Data
28.80    0.00 (0.00%)
Bid:
27.80
Ask:
29.80
Spread: 2.00 (7.194%)
Market Cap: £76.28m
MIG5 Live PriceLast checked at - London Stock Exchange

Intraday Maven I&g Vct5 Share Chart

Dividend Declaration

26 Feb 2026 09:15

RNS Number : 5365U
Maven Income and Growth VCT 5 PLC
26 February 2026
 

 

Maven Income and Growth VCT 5 PLC

(the Company)

 

 

Proposed Final Dividend

 

The Directors propose that a final dividend of 0.30p per Ordinary Share in respect of the year ended 30 November 2025, be paid on 15 May 2026 to Shareholders on the register at close of business on 17 April 2026.

 

As Shareholders will be aware from recent Annual and Interim Reports, decisions on distributions take into consideration a number of factors, including the availability of surplus revenue, the realisation of capital gains, the adequacy of distributable reserves and the VCT qualifying level. The Board and the Manager recognise the importance of tax-free distributions to Shareholders and, subject to the conditions set out above, will target an annual dividend yield that represents 6% of the NAV per Ordinary Share at the preceding year end.

 

Since the Company's launch, and after receipt of this latest final dividend, 56.05p per Ordinary Share will have been distributed in tax-free dividends. It should be noted that the effect of paying dividends is to reduce the NAV of the Company by the total cost of the distribution.

 

Dividend Investment Scheme

 

The Company has in place a Dividend Investment Scheme (DIS) through which Shareholders may elect to have their dividend payments used to apply for new Ordinary Shares issued by the Company under the standing authority requested from Shareholders at Annual General Meetings. Shares issued under the DIS should qualify for VCT tax reliefs applicable for the tax year in which they are allotted. Terms & conditions of the scheme, together with a mandate form, are available from the Company's website at: www.mavencp.com/migvct5

Shareholders who have not previously applied to participate in the DIS and who wish to do so in respect of the dividend payable on 15 May 2026, should ensure that a mandate form is received by the Company's Registrars, The City Partnership (UK) Limited, prior to the dividend election date of 1 May 2026. Election to participate in the DIS can also be made through the Registrar's share portal at https://maven-cp.cityhub.uk.com.

 

Further to the information disclosed above, the Directors confirm that they are satisfied that all inside information (as defined by Article 7 of the Market Abuse Regulation (596/2014/EU)) that the Directors and the Company may have in their possession relating to the Company during the 30 day closed period leading up to the announcement of its annual results for the year ended 30 November 2025 has been or will be notified to a regulatory information service.

 

 

Issued on behalf of the Board

Maven Capital Partners UK LLP

Company Secretary

 

26 February 2026

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVMZGZZLVZGVZG
Date   Source Headline
27th Aug 201312:40 pmRNSNet Asset Value(s)
23rd Aug 201312:30 pmRNSNet Asset Value(s)
22nd Aug 201311:11 amRNSNet Asset Value(s)
21st Aug 201311:15 amRNSNet Asset Value(s)
20th Aug 201310:36 amRNSNet Asset Value(s)
19th Aug 201311:17 amRNSNet Asset Value(s)
16th Aug 201310:58 amRNSNet Asset Value(s)
15th Aug 201312:24 pmRNSNet Asset Value(s)
14th Aug 201312:54 pmRNSNet Asset Value(s)
13th Aug 201311:50 amRNSNet Asset Value(s)
12th Aug 201312:48 pmRNSNet Asset Value(s)
9th Aug 201312:03 pmRNSNet Asset Value(s)
8th Aug 20132:00 pmRNSNet Asset Value(s)
7th Aug 20134:05 pmRNSNet Asset Value(s)
6th Aug 201310:50 amRNSNet Asset Value(s)
5th Aug 201312:18 pmRNSNet Asset Value(s)
2nd Aug 201312:39 pmRNSNet Asset Value(s)
1st Aug 201311:14 amRNSNet Asset Value(s)
31st Jul 201311:56 amRNSNet Asset Value(s)
30th Jul 201311:27 amRNSNet Asset Value(s)
29th Jul 20131:38 pmRNSNet Asset Value(s)
26th Jul 20132:27 pmRNSDirector/PDMR Shareholding
26th Jul 20131:01 pmRNSNet Asset Value(s)
26th Jul 201311:26 amRNSDirector/PDMR Shareholding
26th Jul 20137:00 amRNSHalf Yearly Report
25th Jul 201310:47 amRNSNet Asset Value(s)
24th Jul 201310:50 amRNSNet Asset Value(s)
23rd Jul 201311:51 amRNSNet Asset Value(s)
22nd Jul 201310:29 amRNSNet Asset Value(s)
19th Jul 201311:13 amRNSNet Asset Value(s)
18th Jul 201312:00 pmRNSNet Asset Value(s)
17th Jul 201311:35 amRNSNet Asset Value(s)
16th Jul 201311:13 amRNSNet Asset Value(s)
15th Jul 201312:46 pmRNSNet Asset Value(s)
12th Jul 201311:11 amRNSNet Asset Value(s)
11th Jul 201310:55 amRNSNet Asset Value(s)
10th Jul 201311:20 amRNSNet Asset Value(s)
9th Jul 201311:07 amRNSNet Asset Value(s)
8th Jul 201311:04 amRNSNet Asset Value(s)
5th Jul 201310:23 amRNSNet Asset Value(s)
4th Jul 201312:25 pmRNSNet Asset Value(s)
3rd Jul 201311:04 amRNSNet Asset Value(s)
2nd Jul 201311:06 amRNSNet Asset Value(s)
1st Jul 201311:38 amRNSNet Asset Value(s)
28th Jun 201311:26 amRNSNet Asset Value(s)
27th Jun 201310:44 amRNSNet Asset Value(s)
26th Jun 201312:32 pmRNSNet Asset Value(s)
25th Jun 201310:51 amRNSNet Asset Value(s)
24th Jun 201311:50 amRNSNet Asset Value(s)
21st Jun 201312:28 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.